Chiesi Global Rare Diseases Presents Long-Term Data on Treatment with Velmanase Alfa in Alpha-Mannosidosis and Announces Additional Presentations at the 20th Annual WORLDSymposium™ Research Meeting

– Results presented from over a decade of treatment with velmanase alfa in alpha-mannosidosis – – Company also presents immunogenicity and tolerability data from pegunigalsidase alfa clinical trial program in Fabry disease – – Additional presentations provide new insights on prevalence,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.